Paxlovid does not shorten COVID symptoms among fully vaccinated--study

Among fully vaccinated, study shows Paxlovid does not shorten symptoms A new study in the New England Journal of Medicine suggests that, for those fully vaccinated against COVID-19 but having at least one risk factor for severe COVID, the antiviral drug Paxlovid did little to reduce symptom duration, but experts caution the findings might not apply to older patients. CIDRAP

...

Included in the study were patients who were fully vaccinated and who had at least one risk factor for severe disease, as well as patients without such risk factors who had never been vaccinated against COVID-19, or had not been vaccinated within the previous year.

...